首页> 外文OA文献 >Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors

【2h】

Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors

机译：慢性骨髓白血病术治疗酪氨酸激酶抑制剂时代极端血小板症的临床特征及疗效分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zhihe Liu; Hongqiong Fan; Yuying Li; Chunshui Liu;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors [J] . Zhihe Liu, Hongqiong Fan, Yuying Li, OncoTargets and therapy . 2017,第1期

机译：酪氨酸激酶抑制剂时代慢性粒细胞白血病伴极度血小板增多症的临床特征和疗效分析
2. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lympoblastic Leukemia wit [J] . B. J. Druker, M. Talpaz, D. J. Resta, Chemtracts . 2001,第13期

机译：BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病中的功效和安全性BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病和急性淋巴细胞白血病机智的爆发危机中的活性
3. Extreme thrombocytosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors [J] . Sora Federica, Autore Francesco, Chiusolo Patrizia, Leukemia and lymphoma . 2014,第12期

机译：酪氨酸激酶抑制剂时代慢性粒细胞白血病的极端血小板增多
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. The multi-targeted receptor tyrosine kinase inhibitor, linifanib (ABT-869), induces apoptosis and inhibits proliferation of leukemia cells through phosphoinositide-3 kinase (PI3K)/AKT-dependent signaling pathways. [D] . Hernandez, Jenny Elizabeth. 2010

机译：多靶点受体酪氨酸激酶抑制剂利尼法尼（ABT-869）通过磷酸肌醇3激酶（PI3K）/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
6. Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors [O] . Zhihe Liu, Hongqiong Fan, Yuying Li, 2017

机译：酪氨酸激酶抑制剂时代慢性粒细胞白血病伴极度血小板增多症的临床特征和疗效分析
7. Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia. [O] . Alexander V Lavrov, Oksana A Ustaeva, Elmira P Adilgereeva, 2017

机译：细胞色素和谷胱甘肽中的拷贝数变异分析s-转移酶可预测酪氨酸激酶抑制剂在慢性粒细胞白血病中的功效。

Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅